HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.9
  1. Home
  2. /Compound

Azaserine

HCID 460129
New noteNew reactionRequest quotesPrint preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
115-02-6
Standard SMILES
[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O
InChIKey
MZZGOOYMKKIOOX-VKHMYHEASA-N
Molecular formula
C5H7N3O4
Average molar mass
173.13 g/mol
Monoisotopic mass
173.04365571

Overview

Azaserine can cause cancer according to an independent committee of scientific and health experts.

Names & identifiers

Preferred name
Azaserine
IUPAC
(2S)-2-amino-3-(2-diazoacetyl)oxypropanoic acid
English name
Azaserine
Molecular formula
C5H7N3O4
Molecular weight
173.13

Names & synonyms

azaserine115-02-6O-Diazoacetyl-L-serineL-azaserineAzaserinaL-Serine, diazoacetate (ester)AzaserinumDiazoacetate (ester) L-serineCL 337L-beta-(Diazoacetoxy)alaninNSC-742CN-15,757
Show more names
azsci337cl337ci-337cn15757azaserin
P-165CN 15757Serine, diazoacetate (ester), L-DTXSID9020118Acetic acid, diazo-, ester with serineCL-337NSC742CN-15757

Database identifiers

CAS
115-02-6
PubChem CID
460129
DTXSID
DTXSID9020118
ChEMBL
CHEMBL1095699、CHEMBL442607
ChEBI
CHEBI:74846
UNII
87299V3Q9W
EC Number
204-061-6
Nikkaji
J2.894K

Properties

Computed structural properties

XLogP
-3.2
Topological polar surface area
91.6 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
5
Heavy atoms
12
Formal charge
0
Complexity
233

Experimental & physicochemical properties

Chemical Classes · 2 items

Biological Agents -> Bacterial Toxins

Carcinogens

Color/FormORTHORHOMBIC, PALE YELLOW TO GREEN CRYSTALS FROM 90% ETHANOL.
SolubilitySLIGHTLY SOL IN METHANOL, ABSOLUTE ETHANOL ACETONE; SOL IN WARM AQ SOLN OF METHANOL, ABSOLUTE ETHANOL ACETONE
DecompositionDECOMP 146-162 °C
Melting PointAbout 157 deg
Vapor Pressure1.53X10-10 mmHg at 25 °C.
Optical RotationSPECIFIC OPTICAL ROTATION: -0.5 DEG @ 27.5 °C/D (WATER @ PH 5.18, 8.46%) MAX ABSORPTION (WATER @ PH 7): 250.5 NM (E= 1140, /FOR/ 1% /SOLUTION/, 1 CM /PATH/); (0.1 N SODIUM HYDROXIDE): 252 NM (E= 1230, 1%, 1 CM)
Henry's Law ConstantHenry's Law constant: 2.56X10-16 atm-cu m/mole at 25 °C (est, SRC)
Physical Description · 2 items

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Danger

H301: Toxic if swallowed [Danger Acute toxicity, oral]

Hazard information

Regulatory Information · 3 items

Hazard Traits - Carcinogenicity

Azaserine: Does not have an individual approval but may be used under an appropriate group standard

The New Jersey Worker and Community Right to Know Act requires public and private employers to provide information about hazardous substances at their workplaces. (N.J.S.A. 34:5A-1 et. seq.)

DOT LabelPoison
Fire HazardsExcerpt from ERG Guide 152 [Substances - Toxic (Combustible)]:
Health HazardsExcerpt from ERG Guide 152 [Substances - Toxic (Combustible)]:
Hazards Summary · 2 items

An amino acid antagonist that inhibits the synthesis of proteins and nucleic acids; Causes fatty liver and hepatic necrosis; Emergency treatment: Symptomatic drug ingestion; [HSDB] May cause irritation; Targets kidneys, liver, and bone marrow; [MSDSonline]

The major hazards encountered in the use and handling of azaserine stem from its toxicologic properties. Exposure to this pale yellow-to-green, crystalline substance may occur from its use as a research chemical, or from veterinary applications as an antineoplastic, antibiotic, or abortifacient. Effects from exposure may include hepatic necrosis and fatty liver. Also, the Intern ational Agency for Research on Cancer (IARC) has designated azaserine as a Group 2B carcinogen, ie, "The agent is possibly carcinogenic to humans." Mechanical exhaust ventilation with a high-efficiency particulate arrestor (HEPA) should be used to minimize airborne levels of this substance. In activities and situations where over-exposure may occur, wear protective clothing and a carefully fitted respirator. If contact should occur, irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes, and wash exposed skin thoroughly with soap and water. For shipping and storage, this substance should be enclosed in a securely sealed container which is enclosed in a second unbreakable, leakproof container.

Chemistry & industry

Pharmacology

Mechanism of Action · 4 items

AMINO ACID ANTAGONISTS INHIBIT PROTEIN & NUCLEIC ACID SYNTHESIS BY INTERFERING WITH INCORPORATION OF SPECIFIC AMINO ACIDS REQUIRED FOR PROTEIN OR NUCLEIC ACID SYNTHESIS. THESE CMPD INCL ... AZASERINE ... .

THE GLUTAMINE ... /ANTAGONIST/ AZASERINE ... POTENT ... /INHIBITOR/ OF DE-NOVO PATHWAY OF PURINE NUCLEOTIDE BIOSYNTHESIS. ... INHIBIT/S/ PURINE BIOSYNTHESIS THROUGH FORMATION OF COVALENT BONDS WITH CYSTEINE RESIDUE IN ACTIVE SITE OF KEY ENZYME IN PATHWAY, FORMYLGLYCINAMIDE RIBOTIDE AMIDOTRANSFERASE.

VET: INHIBITS GLUTAMINE USE IN ASPARAGINE BIOSYNTHESIS & IV OR IP USE ENHANCES EFFECT OF L-ASPARAGINASE AGAINST EXPTL SOLID TUMORS. ... ANTIDIURETIC ACTION NOTED IN MICE.

4 ESTABLISHED CELL LINES CONTAINING GAMMA-GLUTAMYL TRANSPEPTIDASE. /A/ POSITIVE CORRELATION WAS OBSERVED BETWEEN CELLULAR GAMMA-GLUTAMYL TRANSPEPTIDASE LEVELS AND SENSITIVITY TO AZASERINE TOXICITY. STRAINS EXPRESSING LOWEST GAMMA-GLUTAMYL TRANSPEPTIDASE ACTIVITIES SHOWED GREATEST RESISTANCE TO AZASERINE TOXICITY.

MeSH Pharmacological Classification · 4 items

Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.

Antimetabolites that are useful in cancer chemotherapy.

Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.

Absorption, Distribution and Excretion · 2 items

VET: ORAL ABSORPTION IS POOR.

... AFTER TREATMENT OF RATS WITH (3)H-AZASERINE THE PANCREAS HAS BEEN SHOWN TO ATTAIN HIGH LEVELS OF RADIOACTIVITY.

Uses & manufacturing

Suppliers

Loading…

Open inquiries

Loading…

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Azaserine appears as pale yellow to green crystals. Used as an antifungal agent.

Light yellow-green solid; [Merck Index] Faintly yellow powder; [MSDSonline]

Stability/Shelf LifeAQ SOLN ARE MOST STABLE @ PH 8
Dissociation ConstantsPKA 8.55

Physicochemical properties

Melting point
146 · 146-162° (dec)
alpha
27.5 · D27.5 -0.5° (c = 8.46% in H2O at pH 5.18)
Boiling point
303.75 °C · 303.75°C (rough estimate)
Density
1.583 · 1.5830 (rough estimate)
refractive index
1.619 · 1.6190 (estimate)
storage temp.
2 · 2-8°C
solubility
2 O: · H2O: 50 mg/mL, clear, yellow
pka
8.55 · 8.55(at 25℃)
form
lyophilized powder
color
Light-yellow needles from EtOH (aq)
optical activity
-0.527 · -0.527.5 (H2O)
Merck
13 · 13,902
BRN
1726602 · 1726602
InChI
1S/C5H7N3O4/c6-3(5(10)11)2-12-4(9)1-8-7/h1,3H,2,6H2,(H,10,11)/t3-/m0/s1
InChIKey
MZZGOOYMKKIOOX-VKHMYHEASA-N
SMILES
N[C@@H](COC(=O)C=[N+]=[N-])C(O)=O
FDA UNII
87299 V3Q9W · 87299V3Q9W
Proposition 65 List
Azaserine
NCI Drug Dictionary
azaserine
IARC
2 B · 2B (Vol. 10, Sup 7) 1987
EPA Substance Registry System
Azaserine (115-02-6)
UNSPSC Code
12352209 · 12352209
NACRES
26 · NA.26
Symbol(GHS)
6 · GHS06,GHS08
Signal word
Danger
Hazard statements
301 · H301-H351
Precautionary statements
201 · P201-P301+P310+P330
PPE
3 · Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
T
Risk Statements
25 · 25-40
Safety Statements
53 · 53-36/37/39-45
RIDADR
3462 · UN 3462 6.1/PG 3
WGK Germany
3 · 3
RTECS
9625000 · VT9625000
F
10 · 10
HazardClass
6.1 · 6.1(b)
PackingGroup
III
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralCarc · Acute Tox. 3 OralCarc. 2
Hazardous Substances Data
115 · 115-02-6(Hazardous Substances Data)
Toxicity
50 in · LD50 in mice, rats (mg/kg/day): 150, 170 orally (Sternberg, Philips)
Reactive GroupAcids, Carboxylic
RCRA Requirements · 1 item

U015; As stipulated in 40 CFR 261.33, when azaserine, as a commercial chemical product or manufacturing chemical intermediate or an off-specification commercial chemical product or a manufacturing chemical intermediate, becomes a waste, it must be managed according to Federal and/or State hazardous waste regulations. Also defined as a hazardous waste is any residue, contaminated soil, water, or other debris resulting from the cleanup of a spill, into water or on dry land, of this waste. Generators of small quantities of this waste may qualify for partial exclusion from hazardous waste regulations (40 CFR 261.5).

Reactivity ProfileAZASERINE is incompatible with acids.
Air and Water ReactionsVery soluble in water.
EPA Hazardous Waste NumberU015; A toxic waste when a discarded commercial chemical product or manufacturing chemical intermediate or an off-specification commercial chemical product or manufacturing chemical intermediate.
CERCLA Reportable Quantities · 1 item

Persons in charge of vessels or facilities are required to notify the National Response Center (NRC) immediately, when there is a release of this designated hazardous substance, in an amount equal to or greater than its reportable quantity of 1 lb or 0.454 kg. The toll free number of the NRC is (800) 424-8802; In the Washington D.C. metropolitan area (202) 426-2675. The rule for determining when notification is required is stated in 40 CFR 302.4 (section IV. D.3.b).

Hazard Classes and Categories · 3 items

Acute Tox. 3 (100%)

Acute toxicity (Oral) - Category 3

Carcinogens

Safety & protection

Fire FightingExcerpt from ERG Guide 152 [Substances - Toxic (Combustible)]:
First AidExcerpt from ERG Guide 152 [Substances - Toxic (Combustible)]:
Storage Conditions · 1 item

PRECAUTIONS FOR "CARCINOGENS": Storage site should be as close as practical to lab in which carcinogens are to be used, so that only small quantities required for ... expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties ...) that bears appropriate label. An inventory ... should be kept, showing quantity of carcinogen & date it was acquired ... Facilities for dispensing ... should be contiguous to storage area. /Chemical Carcinogens/

Cleanup Methods · 1 item

PRECAUTIONS FOR "CARCINOGENS": A high-efficiency particulate arrestor (HEPA) or charcoal filters can be used to minimize amt of carcinogen in exhausted air ventilated safety cabinets, lab hoods, glove boxes or animal rooms ... Filter housing that is designed so that used filters can be transferred into plastic bag without contaminating maintenance staff is avail commercially. Filters should be placed in plastic bags immediately after removal ... The plastic bag should be sealed immediately ... The sealed bag should be labelled properly ... Waste liquids ... should be placed or collected in proper containers for disposal. The lid should be secured & the bottles properly labelled. Once filled, bottles should be placed in plastic bag, so that outer surface ... is not contaminated ... The plastic bag should also be sealed & labelled. ... Broken glassware ... should be decontaminated by solvent extraction, by chemical destruction, or in specially designed incinerators. /Chemical Carcinogens/

Nonfire Spill ResponseExcerpt from ERG Guide 152 [Substances - Toxic (Combustible)]:
Disposal Methods · 5 items

Generators of waste (equal to or greater than 100 kg/mo) containing this contaminant, EPA hazardous waste number U015, must conform with USEPA regulations in storage, transportation, treatment and disposal of waste.

A poor candidate for incineration.

PRECAUTIONS FOR "CARCINOGENS": There is no universal method of disposal that has been proved satisfactory for all carcinogenic compounds & specific methods of chem destruction ... published have not been tested on all kinds of carcinogen-containing waste. ... summary of avail methods & recommendations ... /given/ must be treated as guide only. /Chemical Carcinogens/

PRECAUTIONS FOR "CARCINOGENS": ... Incineration may be only feasible method for disposal of contaminated laboratory waste from biological expt. However, not all incinerators are suitable for this purpose. The most efficient type ... is probably the gas-fired type, in which a first-stage combustion with a less than stoichiometric air:fuel ratio is followed by a second stage with excess air. Some ... are designed to accept ... aqueous & organic-solvent solutions, otherwise it is necessary ... to absorb soln onto suitable combustible material, such as sawdust. Alternatively, chem destruction may be used, esp when small quantities ... are to be destroyed in laboratory. /Chemical Carcinogens/

For more Disposal Methods (Complete) data for AZASERINE (7 total), please visit the HSDB record page.

Preventive Measures · 5 items

PRECAUTIONS FOR "CARCINOGENS": Smoking, drinking, eating, storage of food or of food & beverage containers or utensils, & the application of cosmetics should be prohibited in any laboratory. All personnel should remove gloves, if worn, after completion of procedures in which carcinogens have been used. They should ... wash ... hands, preferably using dispensers of liq detergent, & rinse ... thoroughly. Consideration should be given to appropriate methods for cleaning the skin, depending on nature of the contaminant. No standard procedure can be recommended, but the use of organic solvents should be avoided. Safety pipettes should be used for all pipetting. /Chemical Carcinogens/

PRECAUTIONS FOR "CARCINOGENS": In animal laboratory, personnel should remove their outdoor clothes & wear protective suits (preferably disposable, one-piece & close-fitting at ankles & wrists), gloves, hair covering & overshoes. ... clothing should be changed daily but ... discarded immediately if obvious contamination occurs ... /also,/ workers should shower immediately. In chemical laboratory, gloves & gowns should always be worn ... however, gloves should not be assumed to provide full protection. Carefully fitted masks or respirators may be necessary when working with particulates or gases, & disposable plastic aprons might provide addnl protection. If gowns are of distinctive color, this is a reminder that they should not be worn outside of lab. /Chemical Carcinogens/

PRECAUTIONS FOR "CARCINOGENS": ... Operations connected with synth & purification ... should be carried out under well-ventilated hood. Analytical procedures ... should be carried out with care & vapors evolved during ... procedures should be removed. ... Expert advice should be obtained before existing fume cupboards are used ... & when new fume cupboards are installed. It is desirable that there be means for decreasing the rate of air extraction, so that carcinogenic powders can be handled without ... powder being blown around the hood. Glove boxes should be kept under negative air pressure. Air changes should be adequate, so that concn of vapors of volatile carcinogens will not occur. /Chemical Carcinogens/

PRECAUTIONS FOR "CARCINOGENS": Vertical laminar-flow biological safety cabinets may be used for containment of in vitro procedures ... provided that the exhaust air flow is sufficient to provide an inward air flow at the face opening of the cabinet, & contaminated air plenums that are under positive pressure are leak-tight. Horizontal laminar-flow hoods or safety cabinets, where filtered air is blown across the working area towards the operator, should never be used ... Each cabinet or fume cupboard to be used ... should be tested before work is begun (eg, with fume bomb) & label fixed to it, giving date of test & avg air-flow measured. This test should be repeated periodically & after any structural changes. /Chemical Carcinogens/

For more Preventive Measures (Complete) data for AZASERINE (9 total), please visit the HSDB record page.

Isolation and EvacuationExcerpt from ERG Guide 152 [Substances - Toxic (Combustible)]:
Personal Protective Equipment (PPE) · 2 items

Excerpt from ERG Guide 152 [Substances - Toxic (Combustible)]:

PRECAUTIONS FOR "CARCINOGENS": ... Dispensers of liq detergent /should be available./ ... Safety pipettes should be used for all pipetting. ... In animal laboratory, personnel should ... wear protective suits (preferably disposable, one-piece & close-fitting at ankles & wrists), gloves, hair covering & overshoes. ... In chemical laboratory, gloves & gowns should always be worn ... however, gloves should not be assumed to provide full protection. Carefully fitted masks or respirators may be necessary when working with particulates or gases, & disposable plastic aprons might provide addnl protection. ... gowns ... /should be/ of distinctive color, this is a reminder that they are not to be worn outside the laboratory. /Chemical Carcinogens/

Toxicology

Interactions · 5 items

Chemoprevention by a synthetic retinoid, selenium, and these agents in combination during the postinitiation stages of carcinogenesis induced in rats by azaserine was evaluated. Male Lewis rats were given three weekly injections of 30 mg/kg azaserine while being fed a purified diet. One week after completion of carcinogen treatment, groups of rats were switched to the purified diet supplemented with either a retinoid, N-(2-hydroxethyl)retinamide, at a level of 0.5 or 1 mmol/kg diet, or with 5 ppm sodium selenite, or with a combination of retinoid and selenium. One year after the diet change, the incidence of pancreatic and other neoplasms was determined by autopsy and histologic study. The incidence of pancreatic carcinoma (including carcinoma-in-situ, CIS) among nonretinoid-treated controls was 68%. Since the dietary supplements were fed after completion of exposure to the carcinogen, the effects on both pancreatic and liver carcinogenesis were exerted during postinitiation phase of carcinogenesis. As in previous studies, the retinoid inhibited the progression of pancreatic carcinogenesis in a dose-related fashion. Selenium alone had no effect. However, the combination of retinoid plus selenium was more effective than retinoid alone, although the increase in inhibition was not large. The retinoid was also found to inhibit liver carcinogenesis induced by azaserine. Selenium, either alone or in combination with retinoid, was ineffective.

Effect of dietary intake of fish (menhaden) oil and fish (cod) protein on the development of pancreatic preneoplastic lesions was examined in male Wistar rats. Fourteen day old animals were given a single ip injection of 30 mg L-azaserine/kg body weight; diazoacetate serine (ester). At 21 days of age they were weaned and maintained on dietary treatment for 4 months. Fish protein did not appear to produce a significantly different preneoplastic response when compared to casein as a protein source. However, a 20% menhaden oil diet, rich in omega 3 fatty acids, produced a significant decrease in the development of both the size and number of preneoplastic lesions when compared to a 20% corn oil diet rich in omega 6 fatty acids. This study provides evidence that fish oils, rich in omega 3 fatty acids, may have potential as inhibitory agents in cancer development.

Diets containing raw soybean products fed ad libitum caused a reduction in food consumption and growth, pancreatic enlargement, hypersecretion of digestive enzymes, and enlargement of intestinal segments and their contents in rats, chicks and geese. These effects were found to be related to the concentration of trypsin inhibitor in the diet. ... In long-term studies the incidence of pancreatic nodules was correlated to the level of trypsin inhibitor in the diet. Feeding raw soybean products potentiated the carcinogenic effect of azaserine and meal feeding enhanced the incidence and size of the pancreatic nodules in rats fed raw soybean products.

Effects of coffee and dietary fat (alone and in combination) on the development of preneoplastic lesions in exocrine pancreas were investigated in rats and hamsters, treated with azaserine or N-nitrosobis(2-oxopropyl)amine, respectively. Animals were given the respective diets (5% or 25% corn oil) and coffee (instead of drinking water) within one week after the treatment with carcinogen. At four months postinitiation, the pancreata were quantitatively examined for the number and size of preneoplstic foci. In rats, coffee alone inhibited growth of acidophilic foci and, moreover, slightly inhibited the positive modulating effect of fat on growth of these foci, pointing to a negative rather than a positive interaction between these two life-style factors. In hamsters, coffee alone enhanced growth of cystic foci, whereas fat alone enhanced growth of ductular foci. An interaction between fat and coffee on pancreatic carcinogenesis in hamsters could not be demonstrated.

For more Interactions (Complete) data for AZASERINE (8 total), please visit the HSDB record page.

Environmental Fate · 3 items

TERRESTRIAL FATE: Information pertaining to the biodegradation of azaserine in soil was not located in the available literature. Azaserine should hydrolyze rapidly in moist acidic soils. Azaserine is an amino-acid with a pKa of 8.55(1) that will dissociate in soil in varying proportions that are pH dependent. Ions are not expected to volatilize, nor do they generally adsorb to particulate matter as strongly as do their neutral counterparts(2). Both estimates of the Henry's Law constant of 2.56X10-16 atm-cu m/mole(3) and the vapor pressure of 1.53X10-10 at 25 °C indicate that the volatilization of azaserine from either moist or dry soil surfaces should not be important fate processes(3). An estimated Koc of 7(2) indicates azaserine should be highly mobile in soil(4); and it may leach to ground water if released to soil(SRC).

AQUATIC FATE: Information pertaining to the biodegradation of azaserine in water was not located in the available literature. Azaserine should hydrolyze rapidly in acidic waters. Rate constants for the acid, neutral and base hydrolysis of azaserine in aqueous solution at pHs of 3, 7 and 11 and 25 °C were KA = 328 M-1 hr-1, 2.6X10-4 hr-1 and 6.8X10-3 M-1 hr-1(5), which correspond to half-lives of 2.1 hours, 111 days and 425 days, respectively(SRC). Azaserine is an amino-acid with a pKa of 8.55(1) that will dissociate in natural waters in varying proportions that are pH dependent. Ions are not expected to volatilize, nor do they generally adsorb to sediments as strongly as do their neutral counterparts(2). An estimated Henry's Law constant of 2.56X10-16 atm-cu m/mole at 25 °C(3) indicates that the volatilization of azaserine from natural bodies of water should not be an important fate process(3). An estimated Koc of 7(2) indicates azaserine should not partition from the water column to organic matter(4) contained in sediments and suspended solids; and an estimated bioconcentration factor (log BCF) of -0.10(2) indicates that azaserine should not bioconcentrate among aquatic organisms(SRC).

ATMOSPHERIC FATE: Based upon a vapor pressure of 1.53X10-0 mm Hg at 25 °C, which has been calculated from the water solubility and Henry's Law constant, azaserine is expected to exist almost entirely in the particulate phase in ambient air(2). However, if released to the atmosphere as a gas, the vapor phase reaction of azaserine with photochemically produced hydroxyl radicals is likely to be an important fate process. The rate constant for the vapor-phase reaction of azaserine with photochemically produced hydroxyl radicals has been estimated to be 4.0X10-11 cu cm/molecule-sec at 25 °C; which corresponds to an atmospheric half-life of about 10 hours at an atmospheric concn of 5X10+5 hydroxyl radicals per cu cm(1). Also, both wet and dry deposition can occur.

Adverse EffectsOccupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Medical Surveillance · 1 item

PRECAUTIONS FOR "CARCINOGENS": Whenever medical surveillance is indicated, in particular when exposure to a carcinogen has occurred, ad hoc decisions should be taken concerning ... /cytogenetic and/or other/ tests that might become useful or mandatory. /Chemical Carcinogens/

Soil Adsorption/Mobility · 1 item

Based upon an estimated water solubility of 1.36X10+5 mg/L at 25 °C(1), a Koc for azaserine of 7 has been calculated using regression-derived equations(2,SRC). This Koc value indicates that azaserine should be highly mobile in soil(3), and it should not partition from the water column to organic matter contained in sediments and suspended solids(SRC). In addition, azaserine is an amino-acid with a pKa of 8.55(4) that will dissociate in environmental media in varying proportions that are pH dependent. Generally ions do not adsorb to particulate matter as strongly as their neutral counterparts(2).

Natural Pollution SourcesAzaserine is a compound produced by Streptomyces fragilis(1).
Human Toxicity ExcerptsAZASERINE PRODUCES HEPATIC NECROSIS & FATTY LIVER. /FROM TABLE/
Artificial Pollution Sources · 1 item

As of 1975, azaserine was not commercially manufactured in the US(1). Current production and import/export data were not located in the available literature. It was however, produced in small quantities for research purposes(1). Azaserine has been used in veterinary medicine as an antibiotic, antineoplastic and abortifacient(1). It may be released to the environment via effluents at sites where it is produced or used(SRC).

Carcinogen Classification · 5 items

Azaserine

Group 2B: Possibly carcinogenic to humans

Volume 10: (1976) Some Naturally Occurring Substances

1987

1987

Environmental Bioconcentration · 1 item

Based upon an estimated water solubility of 1.36X10+5 mg/L at 25 °C(1), a bioconcentration factor (log BCF) of -0.10 for azaserine has been calculated using a recommended regression-derived equation(2,SRC). This BCF value indicates that azaserine should not bioconcentrate among aquatic organisms(SRC).

Volatilization from Water/Soil · 1 item

Azaserine is an amino-acid with a pKa of 8.55(1) that will dissociate in environmental media in varying proportions that are pH dependent. Ions are not expected to volatilize from water. The Henry's Law constant of 2.56X10-16 atm- cu m/mole at 25 °C for azaserine has been estimated using a bond contribution method(2). Based upon this Henry's Law constant, volatilization of azaserine from natural bodies of water and moist soil should not be an important fate process(3). Based upon a vapor pressure of about 1.53X10-10 mm Hg at 25 °C, which has been calculated from the water solubility and Henry's Law constant, azaserine is not expected to evaporate from dry surfaces(SRC).

Non-Human Toxicity Excerpts · 5 items

ESCHERICHIA COLI WP2 - REVERSE MUTATION STUDIES: POSITIVE.

DNA REPAIR-DEFICIENT BACTERIAL TESTS: POSITIVE.

AMONG 18 /CHARLES RIVER WISTAR/ RATS GIVEN /WEEKLY/ IP INJECTIONS /OF 5 MG/KG IN SALINE/ & KILLED 12 OR MORE MO AFTER INITIAL TREATMENT, 5 ADENOCARCINOMAS OF PANCREAS & 1 PROBABLE CARCINOMA, ... METASTASES IN LIVER OCCURRED ... NO PANCREATIC OR KIDNEY TUMORS OCCURRED IN 17 CONTROL RATS, INJECTED WITH SALINE ... .

... CHARLES RIVER WISTAR RATS ... GIVEN WEEKLY OR TWICE WEEKLY IP INJECTIONS OF 5 MG/KG BODY WT AZASERINE IN SALINE FOR 6 MO. OF 23 RATS ... 12 OR MORE MO AFTER INITIAL TREATMENT, 9 HAD ADENOCARCINOMAS OF PANCREAS & 3 HAD PROBABLE CARCINOMAS. NO PANCREATIC OR KIDNEY TUMORS OCCURRED IN 17 CONTROL RATS INJECTED WITH SALINE ... .

For more Non-Human Toxicity Excerpts (Complete) data for AZASERINE (21 total), please visit the HSDB record page.

Regulatory information

RCRA Requirements · 1 item

U015; As stipulated in 40 CFR 261.33, when azaserine, as a commercial chemical product or manufacturing chemical intermediate or an off-specification commercial chemical product or a manufacturing chemical intermediate, becomes a waste, it must be managed according to Federal and/or State hazardous waste regulations. Also defined as a hazardous waste is any residue, contaminated soil, water, or other debris resulting from the cleanup of a spill, into water or on dry land, of this waste. Generators of small quantities of this waste may qualify for partial exclusion from hazardous waste regulations (40 CFR 261.5).

CERCLA Reportable Quantities · 1 item

Persons in charge of vessels or facilities are required to notify the National Response Center (NRC) immediately, when there is a release of this designated hazardous substance, in an amount equal to or greater than its reportable quantity of 1 lb or 0.454 kg. The toll free number of the NRC is (800) 424-8802; In the Washington D.C. metropolitan area (202) 426-2675. The rule for determining when notification is required is stated in 40 CFR 302.4 (section IV. D.3.b).

Safety data

F
10
PPE
Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
3
rtecs
VT9625000
ridadr
UN 3462 6.1/PG 3
Toxicity
LD50 in mice, rats (mg/kg/day): 150, 170 orally (Sternberg, Philips)
risk_code
25-40
Signal word
Danger
Symbol(GHS)
GHS06,GHS08
hazard_code
T
safety_code
53-36/37/39-45
hazard_class
6.1(b)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H301-H351
Hazard Classifications
Acute Tox. 3 OralCarc. 2
Precautionary statements
P201-P301+P310+P330
Hazardous Substances Data
115-02-6(Hazardous Substances Data)
Uses · 4 items

Antitumor/antibiotic produced by Streptomyces sp; Used to induce pancreatic cancer in laboratory animals; [Merck Index] Medical and veterinary applications include: antibiotic, antifungal, antineoplastic, and immunosuppressive; Not commercially produced in the US; [HSDB]

MEDICATION

MEDICATION (VET)

RESEARCH CHEMICAL, EG, FOR LEUKEMIA TREATMENT.

U.S. Production · 2 items

(1977) NOT PRODUCED COMMERCIALLY IN USA

(1979) NOT PRODUCED COMMERCIALLY IN USA

Methods of ManufacturingPRODUCED BY A STREPTOMYCES SPECIES OR BY SYNTHESIS.
Applications · 3 items

Usesantineoplastic, amino acid antagonist

UsesReagent used to induce pancreatic cancer in experimental animal models.

General DescriptionPale yellow to green crystals. Used as an antifungal agent.

Upstream & downstream products

Upstream raw materials

Sodium hydroxideMINERAL OILSAmmonium nitrateD-Glucose monohydrateSOAPCalcium carbonateSTREPTOMYCES

Additional notes

DefinitionChEBI: A carboxylic ester resulting from the formal condensation of the carboxy group of diazoacetic acid with the alcoholic hydroxy group of L-serine. An antibiotic produced by a Streptomyces species.